Feasibility of biologic OviTex mesh in ventral mesh rectopexy: a pilot study

Feasibility of biologic OviTex mesh in ventral mesh rectopexy: a pilot study - Pilot VMR OviTex

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON49296

Enrollment

Registered

2020-10-14

Start date

2021-01-06

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intussusception Rectal prolapse

Interventions

Minimal-invasive ventral mesh rectopexy with an OviTex mesh

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Indication for ventral mesh rectopexy Informed consent for OviTex mesh Age of 18 years or older

Exclusion criteria

Exclusion criteria: Mental incompetence Allergy to ovine rumen.

Design outcomes

Primary

Measure	Time frame
To examine the safety and feasibility of using OviTex core PGA during VMR.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)